Cisco's Stock Family

[hunting4pennys]

CBAI - News out...

Cord Blood America Contracts With Center for Stem Cell Awareness to Sell Collection and Storage Services in Florida

2010-01-19 06:00 ET - News Release

LAS VEGAS, Jan. 19 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.

The Center for Stem Cell Awareness, Inc., Sarasota, Florida (www.babyslifeline.com) has contracted to sell these services throughout the state of Florida.

"This is another very important step forward for Cord Blood America. As a direct result of processing and storing cord blood stem cells in our own laboratory, it allows CBAI to contract partners who will sell our services without CBAI's out-of-pocket investment to develop a new territory. We are fortunate to work with The Center for Stem Cell Awareness, and are very pleased to make this announcement," said Matthew Schissler, CBAI co-founder and CEO.

The Center for Stem Cell Awareness, founded by Joan and Jeff Williams, was a personal endeavor based on a real life scenario with their daughter. Realizing that most expectant parents have no idea about the research and medical breakthroughs with cord blood stem cells, they started their company with the goal of providing an educational resource for expectant families and their physicians to draw upon.

About The Center for Stem Cell Awareness, Inc.

Center for Stem Cell Awareness Story:

Ten years ago we decided to save our daughter's cord blood stem cells. Our physicians at that time were aware of this procedure but freely admitted that they had never done this before, not even for one of their patients. At this time, my husband's older sister had just been diagnosed with Leukemia. According to the information we received, Leukemia was a disease that could be treated with using stem cells. We felt that the important power of our daughter's stem cells might offer her protection from this disease and others. One year ago our daughter was diagnosed with juvenile diabetes. Juvenile diabetes is also known as type 1 or insulin dependent diabetes. I am thankful everyday that we saved her stem cells from her cord blood.

When she was diagnosed with diabetes all of her physicians stated that it was probably a wise decision to have saved her cord blood cells, but they did not think anything was being done in conjunction with cord blood stem cells and diabetes. Upon further research we discovered that there are studies underway to determine the best way to use her cord cells to hopefully reverse this disease. We want every expectant parent to know the facts about the importance of cord blood and all the medical advancements in this field. We wanted to allow interested parties to have someone locally to discuss the importance of this decision and answer all of their questions, and to hopefully provide guidance in this decision making process. Most importantly, to allow you to participate in this process at the best pricing possible.

Contact: Joan Williams
www.babyslifeline.com
941-806-8693


____________________

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. , visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
[e-mail]